Page last updated: 2024-12-07

tyrosyl-prolyl-tryptophyl-glycinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tyrosyl-prolyl-tryptophyl-glycinamide: isolated from human brain cortex; acts as both opiate agonist and antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132632
SCHEMBL ID1373185
MeSH IDM0208138

Synonyms (15)

Synonym
144450-13-5
tyr-d-pro-trp-gly-nh2
d-pro(2)-tyr-w-mif-1
tyr-pro-trp-gly-nh2
tyrosyl-prolyl-tryptophyl-glycinamide
tyr-w-mif-1
glycinamide, l-tyrosyl-l-prolyl-l-tryptophyl-
l-tyrosyl-l-prolyl-l-tryptophylglycinamide
(2s)-1-[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide
SCHEMBL1373185
DTXSID20162710
h-tyr-pro-trp-gly-nh2
(s)-n-((s)-1-(2-amino-2-oxoethylamino)-3-(1h-indol-3-yl)-1-oxopropan-2-yl)-1-((s)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamide
CS-0144686
HY-P3087

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"1-fold leftward shift in the dose-response curve."( Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
Gergen, KA; Kastin, AJ; Paul, D; Zadina, JE, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's17 (73.91)18.2507
2000's6 (26.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.96 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.22 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]